Nifty
Sensex
:
:
23587.50
78041.59
-364.20 (-1.52%)
-1176.46 (-1.49%)

Pharmaceuticals & Drugs - API

Rating :
N/A

BSE: 524164 | NSE: IOLCP

420.50
20-Dec-2024
  • Open
  • High
  • Low
  • Previous Close
  •  443.00
  •  457.70
  •  418.00
  •  441.05
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  1329274
  •  5857.61
  •  537.70
  •  330.85

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 2,467.39
  • 24.72
  • 10
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 2,444.93
  • 1.19%
  • 1.49

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 48.19%
  • 15.33%
  • 31.31%
  • FII
  • DII
  • Others
  • 1.63%
  • 0.02%
  • 3.52%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 18.68
  • 2.40
  • -0.79

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 35.29
  • -16.60
  • -2.24

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • -17.82
  • -7.10

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 16.08
  • 16.08
  • 16.08

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 1.51
  • 1.51
  • 1.51

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 8.62
  • 8.62
  • 8.62

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Sep 24
Sep 23
Var%
Jun 24
Jun 23
Var%
Mar 24
Mar 23
Var%
Dec 23
Dec 22
Var%
Net Sales
525.75
545.30
-3.59%
502.38
563.18
-10.80%
503.92
587.21
-14.18%
520.39
523.48
-0.59%
Expenses
484.18
481.10
0.64%
451.27
490.66
-8.03%
454.40
491.91
-7.63%
476.04
480.80
-0.99%
EBITDA
41.57
64.20
-35.25%
51.11
72.52
-29.52%
49.52
95.30
-48.04%
44.35
42.68
3.91%
EBIDTM
7.91%
11.77%
10.17%
12.88%
9.83%
16.23%
8.52%
8.15%
Other Income
6.43
7.11
-9.56%
7.38
7.06
4.53%
7.52
8.73
-13.86%
8.38
6.65
26.02%
Interest
4.12
4.44
-7.21%
2.15
3.95
-45.57%
3.41
4.88
-30.12%
4.30
4.70
-8.51%
Depreciation
17.94
15.69
14.34%
16.82
14.45
16.40%
16.43
12.11
35.67%
16.34
11.75
39.06%
PBT
25.94
51.18
-49.32%
39.52
61.18
-35.40%
37.20
87.04
-57.26%
32.09
32.88
-2.40%
Tax
6.79
13.31
-48.99%
9.55
15.32
-37.66%
9.58
22.26
-56.96%
9.01
9.10
-0.99%
PAT
19.15
37.87
-49.43%
29.97
45.86
-34.65%
27.62
64.78
-57.36%
23.08
23.78
-2.94%
PATM
3.64%
6.94%
5.97%
8.14%
5.48%
11.03%
4.44%
4.54%
EPS
3.26
6.45
-49.46%
5.10
7.81
-34.70%
4.70
11.03
-57.39%
3.93
4.05
-2.96%

Annual Results

Standalone Figures in Rs. Crores /

Consolidated
Description
TTM
Mar 24
Mar 23
Mar 22
Net Sales
2,052.44
2,132.79
2,217.11
2,184.02
Net Sales Growth
-7.51%
-3.80%
1.52%
 
Cost Of Goods Sold
1,370.48
1,396.95
1,547.09
1,570.51
Gross Profit
681.96
735.84
670.02
613.51
GP Margin
33.23%
34.50%
30.22%
28.09%
Total Expenditure
1,865.89
1,902.20
1,991.44
1,925.73
Power & Fuel Cost
-
149.05
131.98
78.18
% Of Sales
-
6.99%
5.95%
3.58%
Employee Cost
-
201.02
168.21
141.30
% Of Sales
-
9.43%
7.59%
6.47%
Manufacturing Exp.
-
47.67
43.07
36.86
% Of Sales
-
2.24%
1.94%
1.69%
General & Admin Exp.
-
9.01
6.54
5.12
% Of Sales
-
0.42%
0.29%
0.23%
Selling & Distn. Exp.
-
51.25
61.85
66.84
% Of Sales
-
2.40%
2.79%
3.06%
Miscellaneous Exp.
-
47.25
32.70
26.92
% Of Sales
-
2.22%
1.47%
1.23%
EBITDA
186.55
230.59
225.67
258.29
EBITDA Margin
9.09%
10.81%
10.18%
11.83%
Other Income
29.71
30.07
25.61
32.04
Interest
13.98
16.10
16.47
8.29
Depreciation
67.53
62.91
46.16
43.26
PBT
134.75
181.65
188.65
238.78
Tax
34.93
47.22
49.51
57.18
Tax Rate
25.92%
26.00%
26.24%
25.43%
PAT
99.82
134.43
139.14
167.67
PAT before Minority Interest
99.82
134.43
139.14
167.67
Minority Interest
0.00
0.00
0.00
0.00
PAT Margin
4.86%
6.30%
6.28%
7.68%
PAT Growth
-42.06%
-3.39%
-17.02%
 
EPS
17.01
22.90
23.70
28.56

Results Balance Sheet

Standalone Figures in Rs. Crores /

Consolidated
Description
Mar 24
Mar 23
Mar 22
Shareholder's Funds
1,611.51
1,507.72
1,392.28
Share Capital
58.71
58.71
58.71
Total Reserves
1,552.80
1,449.01
1,333.57
Non-Current Liabilities
72.89
58.15
56.62
Secured Loans
0.00
0.00
0.00
Unsecured Loans
0.00
0.00
0.00
Long Term Provisions
6.71
1.65
3.01
Current Liabilities
597.10
502.52
575.29
Trade Payables
469.18
314.22
409.29
Other Current Liabilities
54.67
54.28
54.02
Short Term Borrowings
32.76
79.63
42.75
Short Term Provisions
40.49
54.39
69.23
Total Liabilities
2,281.50
2,068.39
2,024.19
Net Block
933.13
751.81
560.64
Gross Block
1,236.94
995.24
761.99
Accumulated Depreciation
303.81
243.43
201.35
Non Current Assets
1,124.63
1,101.74
881.48
Capital Work in Progress
100.87
89.64
105.20
Non Current Investment
17.41
17.41
0.00
Long Term Loans & Adv.
23.62
9.52
10.77
Other Non Current Assets
49.60
233.36
204.87
Current Assets
1,156.87
966.65
1,142.71
Current Investments
2.88
2.56
2.37
Inventories
424.84
325.52
409.89
Sundry Debtors
471.23
505.28
469.80
Cash & Bank
142.89
21.83
139.99
Other Current Assets
115.03
29.86
30.99
Short Term Loans & Adv.
90.12
81.60
89.67
Net Current Assets
559.77
464.13
567.42
Total Assets
2,281.50
2,068.39
2,024.19

Cash Flow

Standalone Figures in Rs. Crores /

Consolidated
Description
Mar 24
Mar 23
Mar 22
Cash From Operating Activity
290.08
122.27
93.05
PBT
181.65
188.65
224.85
Adjustment
60.12
44.41
33.12
Changes in Working Capital
90.33
-63.69
-102.34
Cash after chg. in Working capital
332.10
169.37
155.63
Interest Paid
0.00
0.00
0.00
Tax Paid
-42.02
-47.10
-62.58
Other Direct Exp. Paid
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
Cash From Investing Activity
-191.28
-120.00
-120.52
Net Fixed Assets
-252.93
-217.16
Net Investments
-0.32
-17.80
Others
61.97
114.96
Cash from Financing Activity
-92.50
-4.11
-1.64
Net Cash Inflow / Outflow
6.30
-1.84
-29.11
Opening Cash & Equivalents
1.39
3.23
32.34
Closing Cash & Equivalent
7.69
1.39
3.23

Financial Ratios

Standalone /

Consolidated
Description
Mar 24
Mar 23
Mar 22
Book Value (Rs.)
274.49
256.81
237.15
ROA
6.18%
6.80%
8.28%
ROE
8.62%
9.60%
12.04%
ROCE
12.24%
13.57%
16.25%
Fixed Asset Turnover
1.91
2.52
2.87
Receivable days
83.56
80.26
78.51
Inventory Days
64.21
60.53
68.50
Payable days
102.34
85.35
95.12
Cash Conversion Cycle
45.42
55.45
51.89
Total Debt/Equity
0.02
0.05
0.03
Interest Cover
12.28
12.45
28.12

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.